Muhammad Hamza Habib, Yun Kyoung Ryu Tiger, Danai Dima, Mathias Schlögl, Alexandra McDonald, Sandra Mazzoni, Jack Khouri, Louis Williams, Faiz Anwer, Shahzad Raza
Light chain amyloidosis is a plasma-cell disorder with a poor prognosis. It is a progressive condition, causing worsening pain, disability, and life-limiting complications involving multiple organ systems. The medical regimen can be complex, including chemotherapy or immunotherapy for the disease itself, as well as treatment for pain, gastrointestinal and cardiorespiratory symptoms, and various secondary symptoms. Patients and their families must have a realistic awareness of the illness and of the goals and limitations of treatments in making informed decisions about medical therapy, supportive management, and end-of-life planning...
March 29, 2024: Journal of Clinical Medicine